The Sulfasalazine Market is estimated to be valued at US$ 2.01 billion in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Sulfasalazine Market refers to the global market for the drug Sulfasalazine, which is primarily used to treat inflammatory bowel disease such as...